Review article · 2023 · Open access

Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer

Scott M. Wemlinger, John C. Cambier

European Journal of Immunology, 54(1), e2249947 · Published 10 October 2023 · DOI 10.1002/eji.202249947

Open PDFView at the publisherCite this paper

In brief

“Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer” is a 2023 review article by Scott M. Wemlinger and John C. Cambier, published in European Journal of Immunology. OpenAlex counts 24 citations as of 20 November 2026, which puts it in the top 3% of works published in 2023 by citations. It is open access: the full text is free to read at European Journal of Immunology.

Citations
24
Most cited in
2025 (11)
Field-weighted impact
0.55
References
151
Authors
2

Abstract

B lymphocytes have become a very popular therapeutic target in a number of autoimmune indications due to their newly appreciated roles, and approachability, in these diseases. Many of the therapies now applied in autoimmunity were initially developed to deplete malignant B cells. These strategies have also been found to benefit patients suffering from such autoimmune diseases as multiple sclerosis, type I diabetes, systemic lupus erythematosus, and rheumatoid arthritis, to name a few. These observations have supported the expansion of research addressing the mechanistic contributions of B cells in these diseases, as well as blossoming of therapeutics that target them. This review seeks to summarize cutting-edge modalities for targeting B cells, including monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, chimeric antigen receptor-T cells, and small molecule inhibitors. Efforts to refine B-cell targeted therapy to eliminate only pathogenic autoreactive cells will be addressed as well as the potential for future B-cell-based cellular therapeutics. Finally, we also address approaches that seek to silence B-cell function without depletion.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wemlinger, S. M., & Cambier, J. C. (2023). Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer. European Journal of Immunology, 54(1), e2249947. https://doi.org/10.1002/eji.202249947

MLA 9

Wemlinger, Scott M., and John C. Cambier. “Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer.” European Journal of Immunology, vol. 54, no. 1, 2023, p. e2249947. https://doi.org/10.1002/eji.202249947.

Chicago

Wemlinger, Scott M. and John C. Cambier. 2023. “Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer.” European Journal of Immunology 54 (1): e2249947. https://doi.org/10.1002/eji.202249947.

Harvard

Wemlinger, S. M. and Cambier, J. C. (2023) ‘Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer’, European Journal of Immunology, 54(1), p. e2249947. doi:10.1002/eji.202249947.

IEEE

S. M. Wemlinger and J. C. Cambier, “Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer,” European Journal of Immunology, vol. 54, no. 1, p. e2249947, 2023, doi: 10.1002/eji.202249947.

BibTeX

@article{wemlinger2023therapeutic,
  title     = {{Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer}},
  author    = {Wemlinger, Scott M. and Cambier, John C.},
  journal   = {European Journal of Immunology},
  year      = {2023},
  volume    = {54},
  number    = {1},
  pages     = {e2249947},
  doi       = {10.1002/eji.202249947},
  url       = {https://doi.org/10.1002/eji.202249947}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202455
20251111
202688

Its field-weighted citation impact is 0.55: it has been cited 0.55 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology

  • B cells
  • B-cell depletion
  • B cell-targeted therapy
  • autoimmunity
  • cancer immunotherapy
  • monoclonal antibodies
  • bispecific antibodies
  • antibody-drug conjugates

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Wemlinger, S. M., & Cambier, J. C. (2023). Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancer. European Journal of Immunology, 54(1), e2249947. https://doi.org/10.1002/eji.202249947

How many times has this paper been cited?

24 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at European Journal of Immunology: sign in and open the PDF from this page.

Who wrote this paper?

Scott M. Wemlinger, John C. Cambier.

What is the DOI of this paper?

10.1002/eji.202249947, permanently at https://doi.org/10.1002/eji.202249947. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.